The breast cancer diagnosis technology – called PANProfiler – has been developed by Panakeia and can accurately predict biomarker status from digitally imaged routine pathology samples. The technology has received UKCA and CE certification for clinical use by health services in the UK and EU. Read more
Search
A huge thank you to everyone involved in giving us the platform to partake and to the all the judges and sponsors. 🎉 Read more...